STUDIES ON ANTIULCER AGENTS .1. SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF ETHYL YLMETHYL]-4-DIMETHYLAMINO-5-PYRIMIDINECARBOXYLATE, A NEW H+ K+-ATPASE INHIBITOR POSSESSING MUCOSAL PROTECTIVE ACTIVITY/
K. Terashima et al., STUDIES ON ANTIULCER AGENTS .1. SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF ETHYL YLMETHYL]-4-DIMETHYLAMINO-5-PYRIMIDINECARBOXYLATE, A NEW H+ K+-ATPASE INHIBITOR POSSESSING MUCOSAL PROTECTIVE ACTIVITY/, Chemical and Pharmaceutical Bulletin, 43(1), 1995, pp. 166-168
Ethyl nylmethyl]-4-dimethylamino-5-pyrimidinecarboxylate (2) has been
synthesized and evaluated for antiulcer properties. Compound 2 is a H/K+-ATPase inhibitor that affords mucosal protection against absolute
ethanol-induced gastric lesions in rats after oral and parenteral admi
nistrations. On the other hand, omeprazole, a representative H+/K+-ATP
ase inhibitor, showed mucosal protective action only after oral admini
stration, indicating that it required gastric acid secretion to genera
te activity. The antiulcer activity of 2 in animal models, such as wat
er-immersion Stress-induced gastric ulcer in rats and acidified aspiri
n-induced gastric ulcer in rats, was three times higher than that of c
imetidine.